Europe Acne Medication Market Forecast to 2030
Europe Acne Medication Market Forecast to 2030 – Regional Analysis – by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)
$2,760 – $4,360
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market
Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient’s unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient’s individual needs.
In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity’s AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person’s health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients’ specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.
Europe Acne Medication Market Overview
Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.
Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)
Europe Acne Medication Market Segmentation
The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.
Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.
In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.
By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.
Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.
In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.
Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.
Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030, registering a CAGR of 6.0% from 2023 to 2030. Launch of novel drugs and individualized treatment programs based on cutting-edge technologies and data-driven strategies are among the critical factors attributed to the Europe acne medication market expansion.
Innovative pharmaceutical developments, including topical and systemic medications, have fundamentally reshaped treatment approaches for acne. In 2023, Cosmo granted Glenmark the rights to market the well-liked acne treatment Winlevi (1% clascoterone cream) across Europe thereby broadening the medication’s market reach. In 2022, Sun Pharmaceutical Industries broadened the scope of its collaboration with Cassiopea with respect to an acne treatment. It has signed extension agreements to the license and supply contracts for WINLEVI (clascoterone) cream 1 percent, enlarging the geographical scope to encompass Russia.
Novel drug launches also include advanced formulations with improved efficacy, enhanced safety profiles, and reduced side effects, catering to the evolving needs of individuals seeking effective acne management. According to a statement released in October 2023 by Bausch Health Companies Inc. and its dermatology business-Ortho Dermatologics-Food and Drug Administration (FDA) approved the New Drug Application for CABTREO topical gel composed of 1.2%, 0.15%, and 3.1% clindamycin phosphate, adapalene, and benzoyl peroxide, respectively. This is a topical treatment indicated for acne vulgaris in patients aged 12 or older. CABTREO is the first and only topical triple combination acne therapy approved by the FDA, which is offered in a fixed-dose form. The company aims to make this gel available for patients in Q1 2024.
The introduction of novel medications, such as retinoids, anti-androgens, and immune modulators, has further expanded the therapeutic options available for healthcare professionals and individuals dealing with acne. The continuous introduction of new drugs stimulates competition, fosters innovation, and encourages research and development investments within the dermatological pharmaceutical industry. The heightened focus on personalized and targeted treatment approaches for treating acne forms a foundation for the advent of novel drugs to improve patient outcomes and satisfaction. Thus, the launch of novel drugs significantly contributes to the progress of the Europe acne medication market.
On the contrary, side effects associated with acne medication hampers the growth of Europe acne medication market.
Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.6% share of the Europe acne medication market in 2022, amassing US$ 659.43 million. It is projected to garner US$ 1,149.31 million by 2030 to expand at 7.2% CAGR during 2023-2030.
In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.5% share of the Europe acne medication market in 2022, amassing US$ 1,344.60 million. It is estimated to garner US$ 2,206.23 million by 2030 to expand at 6.4% CAGR during 2023-2030.
By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held 65.3% share of Europe acne medication market in 2022, amassing US$ 1,282.19 million. It is predicted to garner US$ 2,099.65 million by 2030 to expand at 6.4% CAGR during 2023-2030.
Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held 54.6% share of the Europe acne medication market in 2022, amassing US$ 1,072.13 million. It is projected to garner US$ 1,736.91 million by 2030 to expand at 6.3% CAGR during 2023-2030.
In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.6% share of the Europe acne medication market in 2022, amassing US$ 974.65 million. It is estimated to garner US$ 1,634.01 million by 2030 to expand at 6.7% CAGR during 2023-2030.
Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held 29.4% share of Europe acne medication market in 2022, amassing US$ 577.14 million. It is projected to garner US$ 997.62 million by 2030 to expand at 7.1% CAGR during 2023-2030.
Key players operating in the Europe acne medication market are Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA, among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Acne Medication Market Landscape
4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment
5. Europe Acne Medication Market – Key Market Dynamics
5.1 Europe Acne Medication Market – Key Market Dynamics
5.2 Key Market Drivers
5.2.1 Increasing Prevalence of Severe Acne
5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:
6. Acne Medication Market – Europe Market Analysis
7. Europe Acne Medication Market Analysis – by Therapeutic Class
7.1 Retinoids
7.1.1 Overview
7.1.2 Retinoids: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
7.2.1 Overview
7.2.2 Benzoyl Peroxide: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
7.4.1 Overview
7.4.2 Salicylic Acid: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Acne Medication Market Analysis – by Formulation
8.1 Topical Medication
8.1.1 Overview
8.1.2 Topical Medication: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
8.2.1 Overview
8.2.2 Oral Medication: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Acne Medication Market Analysis – by Type
9.1 Prescription Medicine
9.1.1 Overview
9.1.2 Prescription Medicine: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
9.2.1 Overview
9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Acne Medication Market Analysis – by Acne Type
10.1 Non-Inflammatory Acne
10.1.1 Overview
10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
10.2.1 Overview
10.2.2 Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe Acne Medication Market Analysis – by Distribution Channel
11.1 Pharmacies and Drug Stores
11.1.1 Overview
11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
11.2.1 Overview
11.2.2 Retail Stores: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
11.3.1 Overview
11.3.2 E-Commerce: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12. Europe Acne Medication Market – Country Analysis
12.1 Europe
12.1.1 Europe: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.1 Europe: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.2 Germany
12.1.1.3 Germany: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation
12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type
12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.4 France
12.1.1.5 France: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation
12.1.1.5.3 France: Acne Medication Market Breakdown, by Type
12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type
12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.6 UK
12.1.1.7 UK: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation
12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type
12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type
12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.8 Italy
12.1.1.9 Italy: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation
12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type
12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.10 Spain
12.1.1.11 Spain: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation
12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type
12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.12 Rest of Europe
12.1.1.13 Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel
13. Acne Medication Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Almirall SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson & Johnson
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bausch Health Companies Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Galderma SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Pfizer Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GSK Plc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Viatris Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Pierre Fabre SA
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The the Reporting Teams
15.2 Glossary of Terms
Table 1. Europe Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Therapeutic Class
Table 6. Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Formulation
Table 7. Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 8. Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Acne Type
Table 9. Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 10. Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 12. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 13. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 14. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 15. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 16. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 17. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 18. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 19. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 20. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 21. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 22. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 23. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 24. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 25. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 26. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 27. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 28. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 29. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 30. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 31. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 32. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 33. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 34. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 35. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 36. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 37. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 38. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 39. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 40. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 41. Recent Organic Growth Strategies in Acne Medication Market
Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 43. Glossary of Terms, Acne Medication Market
Figure 1. Europe Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acne Medication Market Revenue (US$ Million), 2022-2030
Figure 5. Europe Acne Medication Market Share (%) – by Therapeutic Class (2022 and 2030)
Figure 6. Retinoids: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Benzoyl Peroxide: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Antibiotics: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Salicylic Acid: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Acne Medication Market Share (%) – by Formulation (2022 and 2030)
Figure 12. Topical Medication: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oral Medication: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe Acne Medication Market Share (%) – by Type (2022 and 2030)
Figure 15. Prescription Medicine: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Over-the-Counter Medicine: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Acne Medication Market Share (%) – by Acne Type (2022 and 2030)
Figure 18. Non-Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Inflammatory Acne: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acne Medication Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 21. Pharmacies and Drug Stores: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: Europe Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 26. Germany: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. UK: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Italy: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Spain: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Rest of Europe: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Growth Strategies in Acne Medication Market
The List of Companies – Europe Acne Medication Market
1. Teva Pharmaceutical Industries Ltd
2. Almirall SA
3. Johnson & Johnson
4. Sun Pharmaceutical Industries Ltd
5. Bausch Health Companies Inc
6. Galderma SA
7. Pfizer Inc
8. GSK Plc
9. Viatris Inc
10. Pierre Fabre SA
You must be logged in to post a review.
Reviews
There are no reviews yet.